[ORGANIZATION]
Central Drugs Standard Control Organisation
Featured in 9 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
259 clusters · 931 sources · last updated
Latest: GLP-1 weight-loss drugs linked to muscle loss and serious side effects
Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr
Indian pharmaceutical fraud enforcement
2 clusters · 7 sources · last updated
Latest: Karnataka FDA busts ₹5 crore spurious medicine racket
Indian authorities have launched significant enforcement actions against illegal pharmaceutical operations involving spurious, expired, and counterfeit medicines. In Telangana, officials raided an unlicensed medical sho
Also covered in
-
India to launch first approved dengue vaccine in 2027
[HEALTH] · 5 sources ·
-
India issues health alert over Pakistan-made whitening creams
[HEALTH] · 4 sources ·
-
Abhayrab rabies vaccine batch flagged as substandard in Delhi
[HEALTH] · 5 sources ·
-
Lupin Limited receives U.S. FDA approval and updates insulin trials
[BUSINESS] · 2 sources ·
-
India's Narcotics Control Bureau warns of rising chemsex trend among youth
[HEALTH] · 7 sources ·
-
India cracks down on high‑risk drug manufacturers and medical stores
[HEALTH] · 3 sources ·